Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LUTRATE DEPOT safely and effectively. See full prescribing information for LUTRATE DEPOT. LUTRATE® DEPOT (leuprolide acetate), for depot suspension Initial U.S. Approval: 2018
Medication labelWhy this: Advisory · dailymed-prescription
LUTRATE DEPOT 22.5 mg for 3-month administration (leuprolide acetate) is indicated for treatment of advanced prostate cancer.
- generic_name
- leuprolide acetate
- brand_name
- mannitol solution
- product_names
- leuprolide acetate, mannitol solution
- ndc
- 83831-134, 83831-134-01, 83831-150, 83831-150-22, 83831-135, 83831-135-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en